Skip to main content
Alps Group Inc logo

Alps Group Inc — Investor Relations & Filings

Ticker · ALPS ISIN · KYG0231P1081 LEI · 529900TD0MG2V2GGRC41 Human health and social work activities
Open in API
Filings indexed 10 across all filing types
Latest filing 2026-05-19 Regulatory Filings
Country KY Cayman Islands
Listing — ALPS

About Alps Group Inc

https://alps-holdings.com/

Alps Group Inc operates a fully integrated research and healthcare platform specializing in predictive, preventive, and precision medicine. Its core operations encompass research, medical services, and wellness solutions. Key offerings include DNA and mRNA sequencing, cellular therapy, and a range of anti-aging products. Additionally, the company is involved in the development of pharmaceutical drugs, specifically targeting infections resistant to existing treatments. By integrating research and development with clinical applications, Alps Group Inc provides comprehensive wellness services and advanced medical technologies. The organization aims to make advanced medical interventions accessible through a vertically integrated ecosystem that spans from laboratory research to clinical delivery.

Recent filings

Filing Released Lang Actions
6-K
Regulatory Filings Classification · 81% confidence The document is a Form 6-K filed by a foreign private issuer under the SEC Exchange Act, reporting receipt of a Nasdaq deficiency letter and related compliance information. It is not a financial report (10-K, IR) nor a specific event like an M&A, dividend, management change, or earnings release. Instead, it is a general regulatory/compliance announcement submitted to the SEC. Therefore, it falls under the fallback category Regulatory Filings (RNS).
2026-05-19 English
6-K - Alps Group Inc (0002025774) (Filer)
Board/Management Information Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, Alps Group Inc, with the SEC. The content announces the appointment of a new board member, Mr. Hee H. Lee, including his qualifications and committee assignments. There is no financial data, earnings information, or report publication mentioned. The primary focus is on a change in the company's board of directors. According to the filing definitions, announcements of changes in the company's board of directors or senior management fall under Board/Management Information (MANG). The document length is 3059 characters, which is relatively short but contains substantive information about management changes, not just a brief announcement or a report publication. Therefore, the correct classification is MANG with high confidence.
2026-04-17 English
3 - Alps Group Inc (0002025774) (Issuer)
Director's Dealing
2026-03-25 English
3 - Alps Group Inc (0002025774) (Issuer)
Director's Dealing
2026-03-25 English
3 - Alps Group Inc (0002025774) (Issuer)
Director's Dealing
2026-03-25 English
3 - Alps Group Inc (0002025774) (Issuer)
Director's Dealing
2026-03-25 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.